Harnessing Drug Target / Biomarker Identification to Accelerate Precision Therapies into the Clinic
Time: 3:45 pm
day: Conference Day 2
Details:
- Genetic and metabolic changes in cancer cells present opportunities for targeted drug therapies that would preferentially block tumour cell growth with reduced side effects
- AI-powered systems that utilize genomics, transcriptomics, and clinical data can predict synthetic lethal gene pairs that can be developed as new drug targets and associated biomarkers
- This effort has led to identification of numerous genetic alterations in cancer cells that are being used as biomarkers for a development of new precision oncology therapies
